Evidence map›Paper›PMID 37938825›Full record

ReviewExpert review of cardiovascular therapy

Clinical challenges facing patient participation in cardiac rehabilitation: cigarette smoking.

Diann E Gaalema, Sherrie Khadanga, Quinn R Pack

Open access · greenAbstract readReview
In one paragraph

Review in Expert review of cardiovascular therapy. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Patient Characteristics and Outcomes by Sex and Smoking Status in Pulmonary and Cardiac Rehabilitation.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Diann E GaalemaDepartment of Psychiatry, University of Vermont, Burlington, VT, United States of America.
Sherrie KhadangaCardiac Rehabilitation and Prevention, University of Vermont Medical Center, South Burlington, VT, United States of America.
Quinn R PackDepartment of Healthcare Delivery and Population Sciences, University of Massachusetts Chan Medical School - Baystate, Springfield, MA, United States of America.
Baystate Health · USUniversity of Vermont · USUniversity of Vermont Medical Center · US

Funding

Vermont Center on Behavior and HealthP20GM103644 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HIGGINS, STEPHEN T · 2013 to 2022
$21.3M
Vermont Center on Behavior and HealthP30GM149331 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Stephen T Higgins · 2023 to 2026
$5.6M
Implementing Effective Smoking Cessation Pharmacotherapy for Hospitalized Smokers with Cardiopulmonary DiseaseR01HL156851 · NHLBI · BAYSTATE MEDICAL CENTER, INC. · PI Quinn Russell Pack · 2022 to 2026
$3.3M
Improving Participation in Cardiac Rehabilitation among Lower-Socioeconomic Status Patients: Efficacy of Early Case Management and Financial IncentivesR33HL143305 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI ADES, PHILIP A., GAALEMA, DIANN E · 2019 to 2022
$3.0M
NHLBI NIH HHS R01 HL156851NHLBI NIH HHS R33 HL143305NIGMS NIH HHS P20 GM103644NIGMS NIH HHS P30 GM149331
6 · The paper itself

Abstract

introductionCardiac rehabilitation (CR) is highly effective at reducing morbidity and mortality. However, CR is underutilized, and adherence remains challenging. In no group is CR attendance more challenging than among patients who smoke. Despite being more likely to be referred to CR, they are less likely to enroll, and much more likely to drop out. CR programs generally do not optimally engage and treat those who smoke, but this population is critical to engage given the high-risk nature of continued smoking in those with cardiovascular disease. AREAS COVERED: This review covers four areas relating to CR in those who smoke. First, we review the evidence of the association between smoking and lack of participation in CR. Second, we examine how smoking has historically been identified in this population and propose objective screening measures for all patients. Third, we discuss the optimal treatment of smoking within CR. Fourth, we review select populations within those who smoke (those with lower-socioeconomic status, females) that require additional research and attention. EXPERT OPINION: Smoking poses a challenge on multiple fronts, being a significant predictor of future morbidity and mortality, as well as being strongly associated with not completing the secondary prevention program (CR) that could benefit those who smoke the most.

Indexed as

Cardiac RehabilitationCardiovascular DiseasesCigarette SmokingFemaleHumansPatient ParticipationSocial ClassAdherenceCardiac rehabilitationparticipationsmokingtobaccotreatment

Identifiers

PMID37938825
PMCPMC11567058
OpenAlexW4388501313

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.